Therapy Areas: Autoimmune
30 June 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday that the Ministry of Health, Labour and Welfare in Japan has granted orphan drug designation ...
25 June 2025 - Dermatology specialist Galderma (SWX:GALD) revealed on Wednesday that it has initiated two new phase II clinical trials to evaluate nemolizumab in patients with systemic sclerosis (SSc)...
25 June 2025 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of oncology, autoimmune, cardiov...
23 June 2025 - China-based global biopharmaceutical company Harbour BioMed (HKEX: 02142) announced on Sunday a global strategic collaboration with Japan's Otsuka Pharmaceutical Co Ltd to advance ...
12 June 2025 - Dermatology specialist Galderma (SWX:GALD) announced on Thursday that the UK's National Institute for Health and Care Excellence has issued final draft guidance recommending nemoli...
3 June 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that the US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabr...